This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2026
Grand Nikko Tokyo DaibaTokyo
メニュー

Shiro Akinaga, PhD
NANO MRNA, Co., Ltd. における President and CEO
スピーカー

アジェンダセッション

  • Targeting lncRNA TUG1 for Treatment of Patients with GBM by Using a Novel DDS System for ASO

    , 9:45am
    セッションを見る

このイベントで

前へ
次へ
Dr. Adrian Amador, PhD
Director of Process Chemistry
Cambrex

Shiro を TIDES Asia: Oligonucleotide & Peptide Therapeutics で見る